The present study also identified that lncRNA CDKN2B-AS1 recruited DNMT1 to ADAM10 promoter region, initiated methylation and inhibited ADAM10 expression, thereby diminishing atherosclerosis and promoting cholesterol efflux. This evidence concerns the gene CDKN2B and atherosclerosis.